AU2002366092A1 - 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides - Google Patents

1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides

Info

Publication number: AU2002366092A1
Authority: AU; Australia
Prior art keywords: pyrrolo; pyridine; carboxylic acid; acid amides; amides
Prior art date: 2001-11-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002366092A

Inventor

Manuka Ghosh

George D. Maynard

Christopher J. O'donnell

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Products Inc

Original Assignee

Neurogen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-19

Filing date

2002-11-19

Publication date

2003-06-10

2002-11-19 Application filed by Neurogen Corp filed Critical Neurogen Corp

2003-06-10 Publication of AU2002366092A1 publication Critical patent/AU2002366092A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

AU2002366092A 2001-11-19 2002-11-19 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides Abandoned AU2002366092A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33302701P	2001-11-19	2001-11-19
US60/333,027		2001-11-19
PCT/US2002/037157 WO2003044018A1 (en)	2001-11-19	2002-11-19	1h-pyrrolo[3,2-b]pyridine-3-carboxylic acid amides

Publications (1)

Publication Number	Publication Date
AU2002366092A1 true AU2002366092A1 (en)	2003-06-10

Family

ID=23300941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002366092A Abandoned AU2002366092A1 (en)	2001-11-19	2002-11-19	1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides

Country Status (7)

Country	Link
EP (1)	EP1453831A1 (en)
JP (1)	JP2005516901A (en)
AU (1)	AU2002366092A1 (en)
BR (1)	BR0214301A (en)
CA (1)	CA2467542A1 (en)
MX (1)	MXPA04004711A (en)
WO (1)	WO2003044018A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2865208B1 (en)	2004-01-16	2009-01-16	Sanofi Synthelabo	1,4-DIAZABICYCLO [3.2.1] OCTANECARBOXMIQUE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF
FR2890072A1 (en) *	2005-09-01	2007-03-02	Fournier S A Sa Lab	New pyrrolopyridine derivatives are peroxisome proliferator activated receptor activators useful to treat e.g. hypertriglyceridimia, hyperlipidemia, hypercholesterolemia and diabetes
US20150374705A1 (en)	2012-02-14	2015-12-31	Shanghai Institues for Biological Sciences	Substances for treatment or relief of pain
KR102260403B1 (en)	2013-06-05	2021-06-04	주식회사 씨앤드씨신약연구소	Heterocyclic derivatives and use thereof
GB201317363D0 (en)	2013-10-01	2013-11-13	Eisai Ltd	Novel compounds
WO2023082044A1 (en) *	2021-11-09	2023-05-19	暨南大学	5-formyl heterocyclic amide compound and use thereof
CN116102549B (en) *	2021-11-09	2025-02-11	暨南大学	5-aldehyde heterocyclic amide compounds and their applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5750702A (en) *	1993-10-27	1998-05-12	Neurogen Corporation	Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands

2002
- 2002-11-19 JP JP2003545655A patent/JP2005516901A/en active Pending
- 2002-11-19 CA CA002467542A patent/CA2467542A1/en not_active Abandoned
- 2002-11-19 EP EP02803679A patent/EP1453831A1/en not_active Withdrawn
- 2002-11-19 MX MXPA04004711A patent/MXPA04004711A/en active IP Right Grant
- 2002-11-19 WO PCT/US2002/037157 patent/WO2003044018A1/en active Application Filing
- 2002-11-19 BR BR0214301-1A patent/BR0214301A/en not_active IP Right Cessation
- 2002-11-19 AU AU2002366092A patent/AU2002366092A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2005516901A (en)	2005-06-09
WO2003044018A1 (en)	2003-05-30
EP1453831A1 (en)	2004-09-08
CA2467542A1 (en)	2003-05-30
BR0214301A (en)	2004-10-13
MXPA04004711A (en)	2005-08-16

Similar Documents

Publication	Publication Date	Title
IL160707A0 (en)	2004-08-31	1, 8-naphthyridine derivatives as antidiabetics
AU2002358718A1 (en)	2003-07-15	2-heteroarylcarboxylic acid amides
AU2002361992A1 (en)	2003-07-09	1,4-dihydro-1,4-diphenylpyridine derivatives
HK1080737A1 (en)	2006-05-04	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2002229976A1 (en)	2002-09-04	Imidazopyridines
AU2002352142A1 (en)	2003-06-10	Pyrazolopyridine derivatives
AU2002216028A1 (en)	2002-06-03	Novel carbamate-substituted pyrazolopyridine derivatives
AU2002221827A1 (en)	2002-06-03	Novel lactame-substituted pyrazolopyridine derivatives
AU2002346300A1 (en)	2003-06-19	Diamine derivatives
AU2002328596A1 (en)	2003-05-29	Diamine derivatives
AU2002367323A1 (en)	2003-07-24	Benzothieno (3,2-
AU2003300883A1 (en)	2004-07-09	Substituted 1-benzoyl-3-cyano-pyrrolo(1,2-a)quinolines
AU2002350942A1 (en)	2003-06-30	Imidazolidineacetic acid derivatives
AU2003219661A1 (en)	2003-07-30	Thieno (3, 2-b) pyridones as antiviral compounds
AU2002366092A1 (en)	2003-06-10	1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides
AU2003293886A1 (en)	2004-07-09	(1,7)naphthyridines as pde4 inhibitors
AU2002327093A1 (en)	2003-06-05	1,2-dihydro-2-oxo-1,8-naphthyridine derivative
AU2002314235A1 (en)	2002-12-03	Block copolymer preparation method
AU2002233664A1 (en)	2003-06-05	Naphthyridine derivative
AU2003250090A1 (en)	2004-02-09	2,4-dihydroxybenzoic acid derivatives
AU2002230528A1 (en)	2003-06-17	Standing weightlifting apparatus
AU2002331567A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
AU2002323523A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carbothioamides as antiviral agents
AU2002323066A1 (en)	2003-02-24	Therapeutic 1h-pyrido(4,3-b)indoles
AU2002327568A1 (en)	2003-03-18	4-thioxo-4,7-dihydro-thieno(2,3-b)pyridine-5-carboxamides as ant iviral agents

Legal Events

Date	Code	Title	Description
2004-08-05	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase